Note: Ingredients listed on restricted chemical lists
EC/CAS
7732-18-5
Name of the chemical
Water, distilled, conductivity or of similar purity H2O
Concentration
N/A
EC/CAS
231-791-2
Name of the chemical
Water, distilled, conductivity or of similar purity H2O
Concentration
N/A
General Information
Revision date
2009-09-04
Product name
Ondansetron Injection Premixed
Product Synonyms
Ondansetron Injection
Icons in SDS
Company Information
company name
Pfizer Inc
e-mail address of the competent person responsible for the Safety Data Sheet
pfizer-MSDS@pfizer.com
Section 2
SECTION 2: Hazards identification
Appearance: Colorless solution
Hazard statements
Non-hazardous in accordance with international standards for workplace safety.
Additional information
Short Term: Active ingredient may be harmful if swallowed. May cause eye irritation (based on components) Long Term: May cause effects on central nervous system through prolonged or repeated exposure. Known Clinical Effects: Adverse effects associated with therapeutic use include headache, flushing, and constipation. EU Indication of danger: Not classified Australian Hazard Classification Non-Hazardous Substance. Non-Dangerous Goods. (NOHSC): Note: This document has been prepared in accordance with standards for workplace safety, which require the inclusion of all known hazards of the active substance or its intermediates regardless of the potential risk. The precautionary statements and warnings included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.
